» Articles » PMID: 8246529

Alstonia Species: Are They Effective in Malaria Treatment?

Overview
Date 1993 Sep 1
PMID 8246529
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

A review of the literature on Alstonia species indicates that evidence in support of their effectiveness in the treatment of malaria is controversial. The antiprotozoal activity of the major alkaloid present in Alstonia species, echitamine, was assessed in vitro against Plasmodium falciparum and Giardia intestinalis. Echitamine displayed little antiplasmodial activity, but two quinoline alkaloids from A. coriacea (corialstonine and corialstonidine) were found to have some activity against P. falciparum although this was approximately 10 times less than that of quinine. None of the three Alstonia alkaloids was active against G. intestinalis. These results are discussed in the context of previously published data.

Citing Articles

Synthesis of Bisindole Alkaloids from the Apocynaceae Which Contain a Macroline or Sarpagine Unit: A Review.

Rahman M, Tiruveedhula V, Cook J Molecules. 2016; 21(11).

PMID: 27854259 PMC: 5214337. DOI: 10.3390/molecules21111525.


In vivo antimalarial evaluation of MAMA decoction on Plasmodium berghei in mice.

Adepiti A, Elujoba A, Bolaji O Parasitol Res. 2013; 113(2):505-11.

PMID: 24271081 DOI: 10.1007/s00436-013-3680-0.


Formulation and Evaluation of Alstonia boonei Stem Bark Powder Tablets.

Chime S, Ugwuoke E, Onyishi I, Brown S, Onunkwo G Indian J Pharm Sci. 2013; 75(2):226-30.

PMID: 24019574 PMC: 3757864.


Monoterpenoid indole alkaloids from Alstonia rupestris with cytotoxic, anti-inflammatory and antifungal activities.

Wang W, Cheng M, Wang X Molecules. 2013; 18(6):7309-22.

PMID: 23792896 PMC: 6269722. DOI: 10.3390/molecules18067309.


Monoterpenoid indole alkaloids from Alstonia yunnanensis and their cytotoxic and anti-inflammatory activities.

Cao P, Liang Y, Gao X, Li X, Song Z, Liang G Molecules. 2012; 17(11):13631-41.

PMID: 23159924 PMC: 6268798. DOI: 10.3390/molecules171113631.